4 completed, 4 recruiting, 1 not yet recruiting. 3 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Plasma Cell Disorder: new trials by email Literature Review of Plasma Cell Disorder trials Research Report on Plasma Cell Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-malignant States to Hematologic Malignancies in Firefighters Monoclonal Gammopathy, Complete Blood Count with differential (CBC w/ diff), Clonal hematopoiesis (CHIP) - Clonal Hematopoiesis of Indeterminate Potential, Monoclonal Gammopathy | Recruiting | Wake Forest University Health Sciences | 300 | 2026-06-23 | 2026-07-13 | |
| Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders Daratumumab Injection - Plasma Cell Disorder | Phase 1 / Phase 2 | Recruiting | University of Maryland, Baltimore | 30 | 2025-10-23 | 2025-10-29 |
| High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders 75gm HDAA, 100gm HDAA, 125gm HDAA - Plasma Cell Disorder | Phase 1 | Recruiting | University of Arkansas | 18 | 2024-07-19 | 2026-06-04 |
| Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing Plasma Cell Disorder | Not yet recruiting | Siriraj Hospital | 498 | 2024-04-01 | 2024-03-26 | |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma HDP-101 - Multiple Myeloma, Plasma Cell Disorder | Phase 1 / Phase 2 | Recruiting | Heidelberg Pharma AG | 78 | 2022-02-07 | 2026-09-17 |
| Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer IUO Plasma Cell Disorders Panel - Plasma Cell Disorder | Completed | Becton, Dickinson and Company | 208 | 2021-05-04 | 2023-10-30 | |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression Cyclophosphamide, Fludarabine, Total Body Irradiation - Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia | Phase 3 | Completed | Dartmouth-Hitchcock Medical Center | 21 | 2018-03-28 | 2026-07-17 |
| Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma Tai Chi, Education - Multiple Myeloma, Plasma Cell Disorder | Not applicable | Completed | Mayo Clinic | 29 | 2015-02-01 | 2019-04-19 |
| Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias Lenalidomide, Placebo - Plasma Cell Disorder | Phase 2 | Completed | Boston VA Research Institute, Inc. | 38 | 2005-04-01 | 2016-05-17 |
Neoplasms, Plasma Cell (9) · Multiple Myeloma (3) · Leukemia (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Myeloproliferative Disorders (1) · Paraproteinemias (1) · Primary Myelofibrosis (1)
Neoplasms (9) · Neoplasms by Histologic Type (9) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphoproliferative Disorders (5) · Blood Protein Disorders (3) · Cardiovascular Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Lymphatic Diseases (3) · Vascular Diseases (3) · Paraproteinemias (2) · Anemia (1)
Blood Cell Count (1) · Chromatin Immunoprecipitation Sequencing (1) · Clonal Hematopoiesis (1) · Cyclophosphamide (1) · Educational Status (1) · Granulocyte Colony-Stimulating Factor (1) · Lenalidomide (1) · Mycophenolic Acid (1) · Sugars (1) · Tacrolimus (1) · Tai Ji (1) · Whole-Body Irradiation (1) · daratumumab (1) · fludarabine (1)
Becton, Dickinson and Company (1) · Boston VA Research Institute, Inc. (1) · Dartmouth-Hitchcock Medical Center (1) · Heidelberg Pharma AG (1) · Mayo Clinic (1) · Siriraj Hospital (1) · University of Arkansas (1) · University of Maryland, Baltimore (1) · Wake Forest University Health Sciences (1)
United States (8) · Germany (1) · Hungary (1) · Poland (1) · Portugal (1) · Romania (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Ashraf Badros, MD (1) · Carolina Schinke, MD (1) · Imelda Omana-Zapata, MD, PHD (1) · Kenneth Meehan, MD (1) · Larry Druhan, PhD (1) · Nandita Khera, MD, MPH (1) · Nikhil C Munshi, M.D. (1)